Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

10 questions · 10 findings · 2 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 9 · 90%Low 1 · 10%Moderate 0 · 0%High 0 · 0%

Exposure to gonadotropins for subfertility vs untreated subfertile women and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to gonadotropins for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).

1 finding from 1 review

Exposure to gonadotropins for subfertility vs general population and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).

1 finding from 1 review

GnRH analogues vs untreated subfertile women and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to GnRH analogues for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).

1 finding from 1 review

Exposure to clomiphene citrate for subfertility vs untreated subfertile women and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to clomiphene citrate for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).

1 finding from 1 review

Exposure to clomiphene citrate for subfertility vs general population and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to clomiphene citrate for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).

1 finding from 1 review

Exposure to any ovary‐stimulating drugs for subfertility vs untreated subfertile women and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to any ovary‐stimulating drugs for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).

1 finding from 1 review

Exposure to any ovary‐stimulating drugs for subfertility vs general population and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to any ovary‐stimulating drugs for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).

1 finding from 1 review

Exposure to clomiphene citrate and gonadotropins for subfertility vs untreated subfertile women and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to clomiphene citrate and gonadotropins for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).

1 finding from 1 review

Exposure to clomiphene citrate and gonadotropins for subfertility vs general population and endometrial cancer risk

Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility

It is very uncertain whether exposure to clomiphene citrate and gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).

1 finding from 1 review